LeMaitre Vascular, Inc. ( LMAT ) will begin trading ex-dividend on May 20, 2013. A cash dividend payment of $0.03 per share is scheduled to be paid on June 05, 2013.

LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc. This press release contains other trademarks and trade names of the Company.

Looking at the universe of stocks we cover at Dividend Channel, on 5/20/13, LeMaitre Vascular Inc (NASD: LMAT) will trade ex-dividend, for its quarterly dividend of $0.03, payable on 6/5/13.

BURLINGTON, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, today reported Q1 2013 financial results.

BURLINGTON, May 09, 2013 (GLOBE NEWSWIRE via COMTEX) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) is presenting at the Bank of America Merrill Lynch Health Care Conference at the Encore at Winn Hotel, Las Vegas, NV.

BURLINGTON, Apr 23, 2013 (GLOBE NEWSWIRE via COMTEX) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) is presenting at the 12th Annual Needham Healthcare Conference at the Westin Grand Central Hotel in New York, NY.

This represents a $0.12 annualized dividend and a dividend yield of 1.98%. The ex-dividend date is Monday, May 20th. LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a provider of medical devices and implants for the treatment of peripheral vascular disease.

BURLINGTON, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) is presenting at the Three Part Advisors East Coast IDEAS Conference at the Metro Meeting Center in Boston, MA.

LeMaitre Vascular, Inc. (NASDAQ: LMAT) is a provider of medical devices and implants for the treatment of peripheral vascular disease.

In November, Neovasc finalized an agreement with LeMaitre Vascular, Inc. allowing LeMaitre to exercise its option to purchase certain rights to Neovasc's biological vascular surgical patch product technology on an accelerated basis, at an agreed price ...